When will retatrutide be approved
It plays a key role in energy metabolism, DNA repair, and reducing oxidative stress
However, abruptly stopping at a high dose can cause a rebound in appetite and blood sugar that feels dramatic
The mechanism is determined by the active ingredient, not the route of administration
Goud A, Zhong J, Peters M, Brook RD, Rajagopalan S
Once daily injectable liraglutide (marketed as Victoza for T2DM and Saxenda for obesity) and once weekly injectable semaglutide (marketed as Ozempic for T2DM and Wegovy for obesity) are two additional GLP-1 analogues, sharing 97% and 94% amino acid homology to GLP-1, respectively [ Figure 2 , Table 1 ]